7 I, a structurally modified sinomenine, exerts dual anti‐GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death

Documenti analoghi

• A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
  di: Marvin Xuejun Xu, et al.
  Pubblicazione: (2025)
• Synthesis of Novel Acetyl‐11‐keto‐ β ‐boswellic Acid Derivatives as Potential Anti‐GBM Agents
  di: Mingxia Sun, et al.
  Pubblicazione: (2024)
• The inhibition of necroptosis prevents neuronal death in a mouse model of Alzheimer’s disease pathology
  di: Sebastiaan Moonen, et al.
  Pubblicazione: (2024)
• Simultaneous determination of sinomenine and its metabolites desmethyl‐sinomenine and sinomenine N‐oxide in rat plasma by liquid chromatography tandem mass spectrometry
  di: Ning He, et al.
  Pubblicazione: (2024)
• Orexin‐A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion
  di: Rengzheng Huan, et al.
  Pubblicazione: (2024)